Clinical Trial Update: Real-life Study of How to Intensify Treatment With Xolair (OMALIZUMAB) in Chronic Spontaneous Urticaria

View source ↗

Summary

Real-world study evaluating how to intensify omalizumab treatment for chronic spontaneous urticaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spontaneous Urticaria

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: University Hospital, Lille | Conditions: Spontaneous Urticaria, Chronic | Status: COMPLETED